Who makes [11C]Cimbi-36-5?

[11C]Cimbi-36-5 is developed by Gitte Moos Knudsen.

Last reviewed 2026-04-20 · How we verify

[11C]Cimbi-36-5

Gitte Moos Knudsen · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	[11C]Cimbi-36-5
Sponsor	Gitte Moos Knudsen
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[11C]Cimbi-36-5 CI brief — competitive landscape report
[11C]Cimbi-36-5 updates RSS · CI watch RSS
Gitte Moos Knudsen portfolio CI